2024
Supporting diversity in clinical trials: the equitable breakthroughs in medicine site maturity model
Harris T, Nunez-Smith M, Suttiratana S, Fretz S, Leonard S, Linnander E, Curry L. Supporting diversity in clinical trials: the equitable breakthroughs in medicine site maturity model. Trials 2024, 25: 764. PMID: 39543751, PMCID: PMC11566401, DOI: 10.1186/s13063-024-08594-9.Peer-Reviewed Original ResearchConceptsSocial determinants of healthQuantitative self-report dataDeterminants of healthCommunity engagementHealth care providersRepresentation of diverse populationsSelf-reported dataSocial determinantsCare providersContent validityPotential participantsClinical trial capabilitiesClinical trial diversityDiverse populationsInclusion of diverse participantsClinical trialsAssessment of capabilitiesTrial infrastructureDiverse participantsU.S. sitesClinical researchAbstract BackgroundParticipantsDiversity effortsStructural assessment
2023
Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies
Skydel J, Ramachandran R, Suttiratana S, Ross J, Burns C, Wallach J. Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies. The Journal Of Rheumatology 2023, 51: jrheum.2023-0920. PMID: 38101910, PMCID: PMC10922605, DOI: 10.3899/jrheum.2023-0920.Peer-Reviewed Original Research